Wikidata

(Q61902838)

English

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

clinical trial

In more languages

Statements

title
The Effect, Safety and Pharmacoeconomics of First or Second Level-prophylactic Use of PEG-rhG-CSF in Breast Cancer Patients With Medium-high Risk of Febrile Neutropenia During Chemotherapy (English)
0 references
medical condition
neutropenia
0 references
fever
0 references
start time
20 January 2019
0 references
end time
31 December 2020
0 references
number of participants
2,000
0 references
minimum age
13 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61902838&oldid=2109673571"